2012/01/25

Shionogi Inc. Press Release: STUDY DATA SHOW CUVPOSA® REDUCED CHRONIC SEVERE DROOLING IN PATIENTS AGES 3-16 YEARS-OLD WITH NEUROLOGIC CONDITIONS